Newsfile Corp · PHIO · November 5, 2026
Phio Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Update as It Advances PH-762 Toward Phase 2b Study Initiation

Get the app for more
Explore stock news, insights and company research.
Get the app → Source: Newsfile Corp ↗